Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-08-30 Sale | 2021-09-01 4:38 pm | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 38,400 | $5.1141 | $196,380 | 66,238 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-02-24 Option Award | 2023-02-28 5:23 pm | N/A 2033-02-24 | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 249,080 | $0 | 249,080 (Direct) | View |
2022-02-22 Option Award | 2022-02-24 4:47 pm | N/A 2032-02-22 | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 215,819 | $0 | 215,819 (Direct) | View |
2021-08-30 Exercise | 2021-09-01 4:38 pm | N/A 2026-02-12 | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 38,400 | $0 | 66,238 (Direct) | View |
2021-08-30 Exercise | 2021-09-01 4:38 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 38,400 | $1.52 | 66,238 (Direct) | View |
Ownership | 2021-08-03 4:09 pm | N/A N/A | PIERIS PHARMACEUTICALS INC. | PIRS | Olwill Shane Chief Development Officer | 0 | $0 | 717,888 (Direct) | View |